Advertisement

Podcasts

Advertisement
Leukemia
Immunotherapy
Geriatric Oncology
Health-Care Policy

Ibrutinib and Rituximab vs Standard Chemoimmunotherapy in CLL

This week, we review a report on the combination of ibrutinib and rituximab vs standard chemoimmunotherapy in some patients with chronic lymphocytic leukemia (CLL); a study on cancer statistics in adults aged 85 and older; and a decision from the Centers for Medicare and Medicaid Services (CMS) on coverage of chimeric antigen receptor (CAR) T-cell therapy for Medicare beneficiaries.

Listen now
Bladder Cancer
Global Cancer Care
Prostate Cancer
Solid Tumors

Erdafitinib for FGFR-Altered Advanced Urothelial Carcinoma

This week, we review a phase II trial of erdafitinib in urothelial carcinoma with an FGFR alteration. We also talk about a report from the World Health Organization on tobacco use worldwide. Then, we discuss two recent U.S. Food and Drug Administration approvals in prostate cancer and a rare joint tumor.

Listen now
Breast Cancer
Symptom Management
Gastroesophageal Cancer
Prostate Cancer
Immunotherapy

Overall Survival in MONALEESA-7

This week, we discuss an interim analysis of the MONALEESA-7 trial of the addition of ribociclib to endocrine therapy in pre- or perimenopausal women with advanced hormone receptor–positive, HER2-negative breast cancer. We also talk about a study that examined the relationship between the duration of chemotherapy and body mass index and the development of lymphedema in some patients with breast cancer. Lastly, we present three recent approvals and regulatory communications from the FDA.

Listen now
Colorectal Cancer
Prostate Cancer
Geriatric Oncology
Issues in Oncology

Rates of Early-Onset Colorectal Cancer

This week, we discuss a study that found a disconnect between rates of colonoscopy and recent increases in colorectal cancer incidence in younger adults. In addition, Kimmie Ng, MD, MPH, of Dana-Farber Cancer Institute, offers her insights on the rising rates of colorectal cancer in young adults. Then, we turn to a report on the relationship between androgen-deprivation therapy and rates of Alzheimer disease and dementia in elderly patients with prostate cancer.

Listen now
Lung Cancer
Breast Cancer
Issues in Oncology

Long-Term Results From the National Lung Screening Trial

This week, we discuss long-term results from an extended analysis of the National Lung Screening Trial, and Dr. James Mulshine of Rush University offers his thoughts on these findings. We also review a report on radioactive iodine treatment for hyperthyroidism and long-term risk of death from solid cancers.

Listen now
Colorectal Cancer
Pain Management
Survivorship

ESMO World GI: Findings From the BEACON CRC Trial and More

We discuss two studies on colorectal cancer that were presented at the ESMO World Congress on Gastrointestinal Cancer. We also talk about a recently published study on the prevalence of pain among cancer survivors in the U.S.

Listen now
Lymphoma
Breast Cancer
Immunotherapy
Multiple Myeloma
Biosimilars

ICML 2019: Role of Liquid Biopsy in Lymphoma

In this episode, The ASCO Post's Editor-in-Chief Dr. James Armitage talks about the International Conference on Malignant Lymphoma (ICML), which he attended recently in Lugano, Switzerland; in particular, Dr. Armitage shares insight from a workshop on bridging liquid biopsy into the management of patients with lymphoma. He also discusses two studies from the plenary session looking at the impact of adding lenalidomide to R-CHOP in the management of diffuse large B-cell lymphoma. 

Later in the podcast, we discuss findings from the PHARE trial on adjuvant trastuzumab dosing in HER2-positive breast cancer and we report two recent approvals by the FDA.

Listen now
Multiple Myeloma
Gastroesophageal Cancer
Gastrointestinal Cancer
Prostate Cancer
Immunotherapy

CASSIOPEIA Trial in Multiple Myeloma

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

Listen now
Colorectal Cancer
Breast Cancer
Immunotherapy
Lung Cancer
Gastrointestinal Cancer
Gastroesophageal Cancer
Issues in Oncology

2019 ASCO: Resection of Liver Metastases

In this episode, we discuss more news from the ASCO Annual Meeting, including findings from a study with relevance to surgical oncology, a summary of a study in HER2-positive breast cancer, and a third study on discrimination among hematology/oncology fellows. We also discuss two FDA approvals that took place in the past week.

Listen now
Pancreatic Cancer
Bladder Cancer
Gynecologic Cancers
Lymphoma
Head and Neck Cancer

2019 ASCO: Pancreatic, Urothelial, and Cervical Cancers

In this episode, we discuss more news from the ASCO Annual Meeting, sharing interviews with experts on studies in pancreatic, urothelial, and cervical cancers. We’ll also tell you about a couple of new drug approvals announced this week by the FDA. 

Listen now
Breast Cancer
Lung Cancer
Multiple Myeloma

Selected Studies From the 2019 ASCO Annual Meeting

In this debut episode of The ASCO Post Podcast, experts in breast, prostate, and lung cancers and multiple myeloma provide clinical insights about selected studies presented at the recent ASCO Annual Meeting, plus news from the FDA.

Listen now
Coming Soon

Coming Soon: The ASCO Post Podcast

For nearly a decade, The ASCO Post has been bringing you news about clinical advancements in oncology and hematology. Now, this award-winning coverage comes to you in a new format.

Listen now
Advertisement

Advertisement



;
Advertisement